BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6093450)

  • 1. Modulation of alpha 2-adrenergic receptors of rat vas deferens by adenosine receptors.
    Watanabe Y; Yoshida H
    Adv Exp Med Biol; 1984; 175():133-43. PubMed ID: 6093450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of phospholipase and 2-chloroadenosine treatments on alpha 2-adrenoceptors in rat vas deferens.
    Watanabe Y; Kaminoh Y; Kagiya T; Kawabata H; Yoshida H
    Jpn J Pharmacol; 1984 Jan; 34(1):109-12. PubMed ID: 6325789
    [No Abstract]   [Full Text] [Related]  

  • 3. Increase of [3H]clonidine binding sites induced by adenosine receptor agonists in rat vas deferens in vitro.
    Watanabe Y; Lai RT; Yoshida H
    Eur J Pharmacol; 1982 Dec; 86(2):265-9. PubMed ID: 6297934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between 2-chloroadenosine and alpha-adrenoceptors in rat vas deferens.
    Lai RT; Watanabe Y; Kamino Y; Yoshida H
    Life Sci; 1984 Jan; 34(5):409-18. PubMed ID: 6319943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of reserpine and adenosine agonist on ?(2)-adrenergic receptor of rat vas deferens examined with [(3)H]yohimbine and [(3)H]clonidine.
    Watanabe Y; Kagiya T; Kaminoh Y; Lai RT; Osugi T; Yoshida H
    Neurochem Int; 1985; 7(1):83-8. PubMed ID: 20492902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferens.
    Diamant S; Atlas D
    Biochem Biophys Res Commun; 1986 Jan; 134(1):184-90. PubMed ID: 3004427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glucocorticoids on alpha-2 adrenoceptors in vas deferens of reserpinized rat in organ culture.
    Maeda H; Watanabe Y; Lai RT; Yoshida H
    Life Sci; 1983 Jul; 33(1):39-46. PubMed ID: 6306373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A2A receptor-mediated facilitation of noradrenaline release involves protein kinase C activation and attenuation of presynaptic inhibitory receptor-mediated effects in the rat vas deferens.
    Queiroz G; Talaia C; Gonçalves J
    J Neurochem; 2003 May; 85(3):740-8. PubMed ID: 12694400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of adenosine on receptor sensitivity in the rat vas deferens.
    Long CJ; Stone TW
    Eur J Pharmacol; 1986 Dec; 132(1):11-9. PubMed ID: 3028833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine nucleoside and nucleotide interactions on normal and subsensitive alpha adrenoreceptor responsiveness in guinea-pig vas deferens.
    Holck MI; Marks BH
    J Pharmacol Exp Ther; 1978 Apr; 205(1):104-17. PubMed ID: 204767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
    Minneman KP; Abel PW
    Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of clonidine-tolerance in the rat vas deferens: cross tolerance to other presynaptic inhibitory agents.
    Ishii K; Yamamoto S; Kato R
    Life Sci; 1982 Jan; 30(3):285-92. PubMed ID: 7070209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of alpha 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery.
    Fox AW; Abel PW; Minneman KP
    Eur J Pharmacol; 1985 Oct; 116(1-2):145-52. PubMed ID: 2865157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors.
    Nasseri A; Barakeh JF; Abel PW; Minneman KP
    J Pharmacol Exp Ther; 1985 Aug; 234(2):350-7. PubMed ID: 2991496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of purinergic receptors in the rat vas deferens.
    Taylor DA; Wiese S; Faison EP; Yarbrough GG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):40-5. PubMed ID: 6294281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-clonidine interaction on neurotransmission in the vas deferens of the rat.
    Fiszman ML; Stefano FJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):148-53. PubMed ID: 6098834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prejunctional inhibitory dopamine receptors in the rat isolated vas deferens.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):28-37. PubMed ID: 6121537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Adrenoceptors in the mouse vas deferens and their effects on its response to electrical stimulation.
    Marshall I; Nasmyth PA; Nicholl CG; Shepperson NB
    Br J Pharmacol; 1978 Jan; 62(1):147-51. PubMed ID: 23194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.